{"title": "Ethyl 4-(5-bromo-1H-indol-3-yl)-2,6,6-trimethyl-5-oxo-1,4,5,6,7,8-hexa\u00adhydro\u00adquinoline-3-carboxyl\u00adate", "body": "For biological properties of 1,4-dihydro\u00adpyridines, see: Triggle, (2003 \u25b6); \u015eafak & \u015eim\u015fek (2006 \u25b6). For the introduction of nifedipine into clinical use, see: Gordeev et al. (1998 \u25b6). For a description of the Cambridge Structural Database, see: Allen, (2002 \u25b6). For geometric analysis, see: Cremer & Pople (1975 \u25b6). For hydrogen-bond motifs, see: Bernstein et al. (1995 \u25b6); Etter et al. (1990 \u25b6). For similar structures, see: El-Khouly et al. (2012 \u25b6); \u00d6zt\u00fcrk Yildirim et al. (2012 \u25b6).\n\n\n\nC23H25BrN2O3\n\nM\nr = 457.36Monoclinic, \n\na = 14.0044 (6) \u00c5\nb = 16.8802 (5) \u00c5\nc = 18.8341 (7) \u00c5\u03b2 = 105.582 (4)\u00b0\nV = 4288.7 (3) \u00c53\n\nZ = 8Cu K\u03b1 radiation\u03bc = 2.83 mm\u22121\n\nT = 123 K0.83 \u00d7 0.69 \u00d7 0.48 mm\n\n\n\nAgilent Xcalibur (Ruby, Gemini) diffractometerAbsorption correction: analytical [(Clark & Reid, 1995 \u25b6) in CrysAlis RED (Agilent (2011 \u25b6)] T\nmin = 0.270, T\nmax = 0.51417300 measured reflections8621 independent reflections7227 reflections with I > 2\u03c3(I)\nR\nint = 0.038\n\n\n\n\nR[F\n2 > 2\u03c3(F\n2)] = 0.058\nwR(F\n2) = 0.159\nS = 1.028621 reflections531 parametersH-atom parameters constrained\u0394\u03c1max = 1.31 e \u00c5\u22123\n\u0394\u03c1min = \u22121.01 e \u00c5\u22123\n\n\n\nData collection: CrysAlis PRO (Agilent, 2011 \u25b6); cell refinement: CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 \u25b6); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 \u25b6); molecular graphics: SHELXTL (Sheldrick, 2008 \u25b6); software used to prepare material for publication: SHELXTL."}